Oral administration of RGO at dose of 100 mg/kg in AOM/DSS-treated mice for 17 weeks significantly attenuated serum levels of NO, IL-6 and TNF-α, as well as expression of colonic inflammatory markers iNOS, COX-2, IL-6, IL-1β, and TNF-α [66]. This evidence concerns the gene TNF and infectious otitis media.